Forward Looking Statements

This communication contains forward-looking statements that involve substantial risks, uncertainties, and assumptions. All statements, other than statements of historical fact, included herein regarding Meliodays’ expected future operations, developments, financial results, plans, strategies, objectives, prospects, or opportunities, including, without limitation, those related to the development, regulatory approval, commercialisation, and market potential of MelioOne®, the timing of non-clinical and clinical studies, future financing needs, intellectual property protection, and the potential expansion into additional indications—are forward-looking statements. Forward-looking statements are typically identified by words such as “may,” “will,” “expect,” “believe,” “intend,” “project,” “anticipate,” “estimate,” “plan,” “seek,” “target,” “aim,” “could,” “should,” “potential,” or similar expressions.

These statements are based on management’s current expectations, beliefs, and assumptions regarding future events and trends that may affect Meliodays’ business. They are not guarantees of future performance, and actual results could differ materially from those expressed or implied due to a range of risks and uncertainties. These include, among others, the possibility that MelioOne® may not prove to be safe, effective, or commercially viable; delays or increased costs in research, development, manufacturing, or regulatory approval processes; changes in regulatory or legal requirements within Germany, the EU, or other jurisdictions; competition from existing or emerging therapies in women’s health; challenges in securing, maintaining, or enforcing intellectual property rights; the availability and terms of future financing; market acceptance, reimbursement, and adoption of Meliodays’ products; as well as broader economic, political, and market conditions. Additional uncertainties may arise from supply chain dependencies, evolving scientific or clinical data, shifts within the healthcare landscape, and other factors beyond Meliodays’ control.

Because of these uncertainties, forward-looking statements should not be relied upon as predictions of future events. Meliodays does not undertake any obligation to update or revise such statements to reflect new information, future developments, or changes in circumstances, except as required by law. All forward-looking statements contained herein speak only as of the date of this communication.

Date: 13 October 2025